An Open-label, Phase 2 Basket Study of SEA-CD40 Combination Therapies in Advanced Malignancies

Clinical Trial Grant

Duke Scholars

Principal Investigator April Kelly Scott Salama Medicine, Medical Oncology

Administered By

Duke Cancer Institute

Awarded By

Seattle Genetics, Inc

Start Date

July 23, 2021

End Date

July 21, 2026

Administered By

Duke Cancer Institute

Awarded By

Seattle Genetics, Inc

Start Date

July 23, 2021

End Date

July 21, 2026